Egyptian Journal of Medical Human Genetics

Table 4 Relation of CYP2B6 gene polymorphism and CYP3A4 gene polymorphism with demographic, clinical and laboratory data in AML patients

From: Impact of Cytochromes P450 3A4 and 2B6 gene polymorphisms on predisposition and prognosis of acute myeloid leukemia: an Egyptian case-control study

	CYP2B6 gene polymorphism			CYP3A4 gene polymorphism
	Wild	Hetero + Homo	p value	Wild	Hetero + Homo	p value
Median Age (years)	32.4	37.6	0.379	35.4	40.1	0.418
Sex, No (%)
Male	14 (48.2%)	15 (51.8%)	0.704	19 (65.5%)	10 (34.5%)	0.547
Female	9 (42.8%)	12 (57.2%)	0.704	12 (57.1%)	9 (42.9%)
Splenomegaly, No. (%)	15 (55.5%)	12 (44.5%)	0.141	17 (63.0%)	10 (37.0%)	0.879
Hepatomegaly, No. (%)	12(54.5%)	10 (45.5%)	0.282	14(63.6%)	8(36.4%)	0.833
Hemoglobin (g/dL)	7.5 ± 1.4	7.9 ± 2.0	0.476	7.8 ± 1.9	8.1 ± 1.9	0.535
Median TLC (×10³/mm³)	42.8	56.4	0.722	60.3	53.4	0.542
Median Platelet count (×10³/mm³)	68.4	50.8	0.784	78.6	66.4	0.810

Back to article page